Sangamo Therapeutics, Inc.SGMONASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
3.36
↓ 70% below average
Average (9y)
11.28
Historical baseline
Range
High:34.33
Low:0.50
CAGR
-14.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.36 | +576.0% |
| 2023 | 0.50 | -87.0% |
| 2022 | 3.84 | -55.4% |
| 2021 | 8.61 | -49.3% |
| 2020 | 17.00 | +92.9% |
| 2019 | 8.81 | -25.6% |
| 2018 | 11.84 | -65.5% |
| 2017 | 34.33 | +237.8% |
| 2016 | 10.16 | -29.2% |
| 2015 | 14.35 | - |